LONDON, April 2, 2014 /PRNewswire/ --
On Tuesday, April 1, 2014, the
NASDAQ Composite ended at 4,268.04, up 1.64%, the Dow Jones
Industrial Average advanced 0.46% to finish at 16,532.61, and the
S&P 500 closed at 1,885.52, up 0.70%. The gains were broad
based with eight out of ten sectors finishing the session in
positive. The S&P 500 Health Care Sector Index finished the day
at 681.72, up 0.70%, and the index has gained 6.14% in the previous
three months. Investor-Edge has initiated coverage on the following
equities: Abbott Laboratories (NYSE: ABT), Medtronic Inc. (NYSE:
MDT), Hologic Inc. (NASDAQ: HOLX) and ArthroCare Corp. (NASDAQ:
ARTC). Free technical research on ABT, MDT, HOLX and ARTC can be
downloaded upon signing up at:
http://www.investor-edge.com/705-register
On Tuesday, shares in Abbott Laboratories finished the session
0.10% lower at $38.47. A total of
5.63 million shares were traded, which is below the three months
average volume of 8.36 million shares. The stock fluctuated between
$38.23 and $38.83 during the session.
Shares of the company traded at a PE ratio of 20.45. Abbott
Laboratories'stock has advanced 0.05% in the previous three trading
sessions and 0.37% on YTD basis, whereas the stock has fallen by
3.29% in the last one month. The stock is trading above its 50-day
and 200-day moving averages. Abbott Laboratories'50-day moving
average of $38.41 is above its
200-day moving average of $36.75.
Moreover, shares of the company have a Relative Strength Index
(RSI) of 44.96. Sign up today to read free research on ABT at:
http://www.investor-edge.com/705-ABT-02Apr2014.pdf
Medtronic Inc.'s stock registered a trading volume of 4.63 million
shares, as compared with a three months average volume of 5.24
million shares. The stock ended the day at $61.61, up 0.11% after vacillating between
$61.39 and $62.20. Shares of the company traded at a PE
ratio of 16.71. Medtronic Inc.'s shares have gained 4.12% in the
previous three trading sessions, 3.97% in the last one month, and
7.35% on YTD basis. The company's stock is trading above its 50-day
and 200-day moving averages. Medtronic Inc.'s 50-day moving average
of $58.03 is above the 200-day moving
average of $56.00. Additionally,
shares of the company have an RSI of 68.01. Sign up today to read
free research on MDT at:
http://www.investor-edge.com/705-MDT-02Apr2014.pdf
On Tuesday, Hologic Inc.'s stock gained 1.30%, to end the day at
$21.78. The stock recorded a trading
volume of 1.69 million shares as compared to a three months average
volume of 2.47 million shares. The stock oscillated between
$21.50 and $21.81 during the trading
session. Hologic Inc.'s shares have gained 4.93% in the previous
three trading sessions, while the same have fallen by 2.55% on YTD
basis. The stock is trading above its 50-day and 200-day moving
averages. Hologic Inc.'s 200-day moving average of $21.55 is above its 50-day moving average of
$21.47. Moreover, shares of the
company have an RSI of 50.59. Sign up today to read free research
on HOLX at:
http://www.investor-edge.com/705-HOLX-02Apr2014.pdf
Shares in ArthroCare Corp. reported a trading volume of 0.45
million shares, as compared with a three months average volume of
0.60 million shares. The stock ended the day at $48.24, up 0.10% and at an intraday range of
$48.10 and $48.44. Shares of the company traded at a PE
ratio of 31.86. ArthroCare Corp.'s shares have gained 0.04% in the
previous three trading sessions and 19.88% on YTD basis, but they
have edged 0.02% lower in the last month. The stock is trading
above its 50-day and 200-day moving averages. ArthroCare Corp.'s
50-day moving average of $48.16 is
above its 200-day moving average of $39.44. Furthermore, the shares of the company
have an RSI of 53.87. Sign up today to read free research on ARTC
at:
http://www.investor-edge.com/705-ARTC-02Apr2014.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge
